Everolimus 10mg daily

DRUG2 trials

Sponsors

Julie E. Bauman, MD, MPH, Xuanwu Hospital, Beijing

Conditions

Squamous Cell Carcinoma of the Head and NeckVascular Malformations

Phase 2

Phase II Study of RAD001 Head and Neck Cancer

TerminatedNCT01051791

Julie E. Bauman, MD, MPHSquamous Cell Carcinoma of the Head and Neck

Start: 2010-01-31End: 2016-08-05Updated: 2017-12-19

An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations

RecruitingNCT07037238

Xuanwu Hospital, BeijingVascular Malformations

Start: 2025-07-01End: 2026-12-31Target: 10Updated: 2025-09-05